HENNIGSDORF
Germany
36
2024-08-15
15
2025-03-11
These are the the leading inventors for applications assigned to SPHINGOTEC GMBH:
SPHINGOTEC GMBH based in HENNIGSDORF, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
A METHOD FOR PREDICTING SEPSIS AND SEPTIC SHOCK
#2 | 2024-08-01MATURE ADRENOMEDULLIN FOR THERAPY STRATIFICATION OF CORTICOSTEROIDS IN CRITICALLY ILL PATIENTS
#3 | 2024-03-28 β Patent 12,247,988 granted on 2025-03-11Adrenomedullin assays and methods for determining mature andrendomedullin
#4 | 2024-03-14 β Patent 12,228,581 granted on 2025-02-18Adrenomedullin assays and methods for determining mature andrendomedullin
#5 | 2023-11-09Anti-ADM-antibodies binding to the free N-terminus for accelerated transition of ADM-Gly to bio-ADM in patients with ADM-Gly/ bio-ADM ratio above a threshold and combination with vitamin C
#6 | 2023-07-13ADRENOMEDULLIN (ADM) FOR DIAGNOSIS AND/OR PREDICTION OF DEMENTIA AND ANTI-ANDRENOMEDULLIN BINDER FOR USE IN THERAPY OR PREVENTION OF DEMENTIA
#7 | 2023-05-11METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT
#8 | 2023-04-27METHOD FOR PREDICTING THE RISK OF INCIDENCE OF CHRONIC KIDNEY DISEASE
#9 | 2022-09-15A METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNCTION IN PEDIATRIC PATIENTS
#10 | 2022-02-10SELENOPROTEIN P IN HEART FAILURE
#11 | 2021-10-07 β Patent 11,726,101 granted on 2023-08-15Adrenomedullin assays and methods for determining mature adrenomedullin
#12 | 2021-09-30ADRENOMEDULLIN (ADM) FOR DIAGNOSIS AND/OR PREDICTION OF DEMENTIA AND ANTI-ADRENOMEDULLIN BINDER FOR USE IN THERAPY OR PREVENTION OF DEMENTIA
#13 | 2021-09-16PRO-ADRENOMEDULLIN OR FRAGMENT THEREOF IN PATIENTS INFECTED WITH CORONA VIRUS AND TREATMENTS WITH BINDER AGAINST ADRENOMEDULLIN
#14 | 2021-07-22METHOD FOR THE DETECTION OF APOLIPOPROTEIN E4
#15 | 2021-01-14 β Patent 11,340,240 granted on 2022-05-24Method for predicting the risk of obesity in a subject
#16 | 2020-11-05 β Patent 11,844,812 granted on 2023-12-19Selenoprotein P for prediction of a first cardiovascular event
#17 | 2020-09-24METHOD FOR PREDICTING THE RISK OF GETTING A MAJOR ADVERSE CARDIAC EVENT
#18 | 2020-08-06ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE
#19 | 2020-06-11A METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNTION
#20 | 2020-02-13FASTING LEVELS OF GROWTH HORMONE AS A PREDICTIVE MARKER OF CARDIOVASCULAR RISK
#21 | 2019-12-12ADRENOMEDULLIN FOR ASSESSING CONGESTION IN A SUBJECT WITH ACUTE HEART FAILURE
#22 | 2018-08-30 β Patent 10,900,978 granted on 2021-01-26Method for predicting the risk of obesity in a subject
#23 | 2018-05-10 β Patent 11,598,781 granted on 2023-03-07Method for predicting the risk of incidence of chronic kidney disease
#24 | 2017-10-26METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT
#25 | 2017-08-17hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a Subject
#26 | 2017-02-23 β Patent 11,067,586 granted on 2021-07-20Adrenomedullin assays and methods for determining mature adrenomedullin
#27 | 2017-01-12 β Patent 10,598,674 granted on 2020-03-24Adrenomedullin to guide therapy of blood pressure decline
#28 | 2016-09-01A METHOD FOR PREDICTING THE RISK OF GETTING A MAJOR ADVERSE CARDIAC EVENT
#29 | 2016-04-07METHOD FOR STRATIFYING A FEMALE SUBJECT FOR HORMONE REPLACEMENT THERAPY
#30 | 2015-12-03FASTING LEVELS OF GROWTH HORMONE AS A PREDICTIVE MARKER OF CARDIOVASCULAR RISK
#31 | 2015-12-03 β Patent 10,605,812 granted on 2020-03-31Method for predicting the risk of getting cancer or diagnosing cancer in a subject
#32 | 2015-09-24 β Patent 9,702,876 granted on 2017-07-11Method for predicting the risk of getting cancer or diagnosing cancer in a female subject
#33 | 2015-02-26 β Patent 10,520,512 granted on 2019-12-31Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject
#34 | 2014-10-30 β Patent 9,535,060 granted on 2017-01-03Adrenomedullin assays and methods for determining mature adrenomedullin
#35 | 2011-11-10 β Patent 9,188,591 granted on 2015-11-17Use of precursors of tachykinins and/or their fragments in medical diagnostic
#36 | 2010-03-11 β Patent 8,916,388 granted on 2014-12-23In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative disorders
Also check out SPHINGOTEC GMBH's (Hennigsdorf, Germany) applicant profile with 14 patent applications submitted.
81417 β